The table below shows IOVANCE BIOTHERAPEUTICS, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$72.07M
-$103.69M
-$122.28M
-$99.81M
-$73.80M
-$62.39M
Capital expenditure
$6.61M
$6.21M
$4.17M
$5.66M
$11.44M
$10.71M
Investing cash flow
$11.39M
$15.87M
-$111.51M
$153.40M
$86.52M
$77.21M
Dividends paid
-
-
-
-
IOVA operating cash flow (10-K history)
IOVANCE BIOTHERAPEUTICS, INC. reported operating cash flow of -$302.41M for fiscal year 2025. That is up 14.3% from -$352.98M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$32.67M (FY 2016) to -$302.41M. Figures come from the company's audited annual reports as filed with the SEC.
